EA201301021A1 - Применение пригодной для распыления композиции, содержащей амброксол - Google Patents

Применение пригодной для распыления композиции, содержащей амброксол

Info

Publication number
EA201301021A1
EA201301021A1 EA201301021A EA201301021A EA201301021A1 EA 201301021 A1 EA201301021 A1 EA 201301021A1 EA 201301021 A EA201301021 A EA 201301021A EA 201301021 A EA201301021 A EA 201301021A EA 201301021 A1 EA201301021 A1 EA 201301021A1
Authority
EA
Eurasian Patent Office
Prior art keywords
ambroadable
application
ambroxol
composition containing
composition
Prior art date
Application number
EA201301021A
Other languages
English (en)
Other versions
EA027291B1 (ru
Inventor
Зандра Зауэрланд
Юлия Бони
Бернд Пломанн
Original Assignee
Бёрингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бёрингер Ингельхайм Интернациональ Гмбх filed Critical Бёрингер Ингельхайм Интернациональ Гмбх
Publication of EA201301021A1 publication Critical patent/EA201301021A1/ru
Publication of EA027291B1 publication Critical patent/EA027291B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

В заявке описан гидрохлорид амброксола для лечения острого фарингита, применяемый местно в дозе от 1 до 20 мг в составе пригодной для распыления композиции, содержащей гидрохлорид амброксола в количестве до 30 мг/мл.
EA201301021A 2011-03-14 2012-03-13 Способ лечения острого фарингита с помощью гидрохлорида амброксола EA027291B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11158043 2011-03-14
PCT/EP2012/054406 WO2012123466A1 (de) 2011-03-14 2012-03-13 Verwendung einer sprühfähigen zusammensetzung enthaltend ambroxol

Publications (2)

Publication Number Publication Date
EA201301021A1 true EA201301021A1 (ru) 2014-03-31
EA027291B1 EA027291B1 (ru) 2017-07-31

Family

ID=44501830

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201301021A EA027291B1 (ru) 2011-03-14 2012-03-13 Способ лечения острого фарингита с помощью гидрохлорида амброксола

Country Status (11)

Country Link
US (1) US10959964B2 (ru)
EP (1) EP2685960B1 (ru)
JP (1) JP5930332B2 (ru)
AR (1) AR085801A1 (ru)
BR (1) BR112013023337A2 (ru)
CA (1) CA2829832C (ru)
EA (1) EA027291B1 (ru)
ES (1) ES2715614T3 (ru)
MX (1) MX2013010456A (ru)
UA (1) UA112541C2 (ru)
WO (1) WO2012123466A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112168783A (zh) * 2020-10-26 2021-01-05 山东裕欣药业有限公司 一种呼吸系统药物口服喷雾剂及制备方法
CN112168782A (zh) * 2020-10-26 2021-01-05 山东裕欣药业有限公司 一种呼吸系统药物口服喷雾剂的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159459A (en) * 1995-05-01 2000-12-12 Colgate Palmolive Company Oral lubricating composition
JPH10259124A (ja) * 1997-03-19 1998-09-29 Taisho Pharmaceut Co Ltd 咽頭疾患用組成物
US20050075403A1 (en) * 2003-10-02 2005-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of inflammation in the pharynx
ITMI20032463A1 (it) 2003-12-16 2005-06-17 Advance Holdings Ltd Soluzione acquosa concentrata a base di ambroxolo
DE102004021992A1 (de) * 2004-05-03 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Topische Zubereitung enthaltend Ambroxol
CN1695601A (zh) * 2005-05-18 2005-11-16 湖北南洋药业有限公司 盐酸氨溴索气雾剂及其制备方法
CA2619863A1 (en) 2005-08-25 2007-03-01 Boehringer Ingelheim International Gmbh Use of ambroxol for the treatment of rhinovirus infections
EP1820493A3 (en) * 2006-02-10 2008-05-07 PARI Pharma GmbH Aerosols for sinunasal drug delivery
CN101606903A (zh) * 2008-06-19 2009-12-23 北京韩美药品有限公司 一种氨溴索的雾化吸入用溶液剂及其制备方法
CN101810604A (zh) * 2009-02-25 2010-08-25 北京利乐生制药科技有限公司 一种以沙丁胺醇与氨溴索为活性成分的喷雾剂

Also Published As

Publication number Publication date
JP2014511828A (ja) 2014-05-19
MX2013010456A (es) 2013-10-28
JP5930332B2 (ja) 2016-06-08
UA112541C2 (uk) 2016-09-26
EP2685960A1 (de) 2014-01-22
BR112013023337A2 (pt) 2016-12-13
US20140066518A1 (en) 2014-03-06
EA027291B1 (ru) 2017-07-31
AR085801A1 (es) 2013-10-30
CA2829832C (en) 2019-07-30
US10959964B2 (en) 2021-03-30
WO2012123466A1 (de) 2012-09-20
ES2715614T3 (es) 2019-06-05
CA2829832A1 (en) 2012-09-20
EP2685960B1 (de) 2018-12-19

Similar Documents

Publication Publication Date Title
PH12016500072A1 (en) Piperidinyl-indole derivatives complement factor b inhibitors and uses thereof
RS54873B1 (sr) Policiklična-karbamoilpiridonska jedinjenja i njihova farmaceutska upotreba
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
IN2015DN00185A (ru)
MX2013012542A (es) Compuestos de amida y aplicacion farmaceutica para el mismo.
BR112012026767A2 (pt) composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, método para tratar ou previnir distúrbios, e, uso de um composto ou sal
NZ712270A (en) Pharmaceutical composition of s-ketamine hydrochloride
CY1119798T1 (el) Μορφη iv υδροχλωρικης ιβαμπραδινης
PH12015501993A1 (en) Pyrazole-amide compound and medicinal uses therefor
MX2016000675A (es) Derivados de amino-metil-biarilo como inhibidores del factor de complemento d y usos de los mismos.
MX2016004741A (es) Composicion farmaceutica que comprende un antagonista de trpa1 y un agente analgesico.
UA115357C2 (uk) Похідні піридин-4-ілу
GT201400003A (es) Una nueva composición terapéutica que contiene apomorfina como principio activo
AR085616A1 (es) Composicion farmaceutica inhalable que comprende glicopirrolato, uso
CO6920289A2 (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib.
RS54475B1 (en) NEW COMBINATION
MX2015007940A (es) Compuestos tricíclicos como inhibidores de cftr.
AR091888A1 (es) Compuestos de urea y su uso como inhibidores de enzimas
NZ717192A (en) Anti-inflammatory tripeptides
AR072426A1 (es) Uso de nifurtimox para el tratamiento de enfermedades causadas por tricomonadida
EA201301021A1 (ru) Применение пригодной для распыления композиции, содержащей амброксол
NZ715554A (en) Method of treating hypertrophic cardiomyopathy
UA118008C2 (uk) Спосіб синтезу (2е)-3-(3,4-диметоксифеніл)проп-2-еннітрилу та застосування в синтезі івабрадину та його адитивних солей з фармацевтично прийнятною кислотою
TN2015000058A1 (en) Salts of benzothiazolone compound as beta-2-adrenoceptor agonist
CL2011002444A1 (es) Composicion farmaceutica que contiene un liposoma y el compuesto activo eribulina o su sal farmacologicamente permisible en la fase interna del liposoma; y el metodo de manufactura de la composicion de liposoma.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KG MD TJ TM